2.9 C
London
Tuesday, January 25, 2022

Pharma companies will get opportunity to make money, 5 companies will get 7,000 crore IPO

- Advertisement -spot_imgspot_img
- Advertisement -

The best performance was in the IPO sector during the financial year 2020-21. Shares of the pharma company performed the best throughout the year as the Sensex and Nifty reached new peaks.

IPO

Amid fears of the ongoing second wave and third wave of COVID-19 in the country, many pharmaceutical manufacturers and life sciences companies are preparing to raise more than Rs 7,000 crore through IPO from the capital market during the next few months. Huh. According to investment bankers Glenmark Lifesciences, pharmaceutical company Supriya Lifesciences, pharmaceutical formulation company Windlass Biotech, Emcure Pharma and Veeda Clinical Research funded by CX Partners Has planned to launch an initial public offering (IPO).

Expected to raise 7 thousand crores

According to Investment Banker, these companies are planning to raise more than Rs 7,000 crore from the capital market through IPO. The IPO sector was the best performer during FY 2020-21. As the Sensex and Nifty reached the new peak, the pharma company’s performance was the best throughout the year.

Pharma shares get more than 500 percent return

Shares of Arti Pharma company got 501 percent return in the year 2020-21, shares of Granuels jumped 201 percent, shares of J&B Chem increased by 145 percent, Aurbindo Pharma ( Aurobindo Pharma) returns doubled. Divi shares rose 104 percent, Ipca Labs rose 97 percent and Ajanta Pharma shares rose 72 percent. This is the reason that the Bombay Stock Exchange’s Health Group Index reached a new peak during the year.

The Indian market has supplied 50 per cent of the vaccines to the world market, while 40 per cent of generic drugs are supplied to the US and 25 per cent to the UK. During the financial year 2019-20, there was a turnover of 1.4 lakh crores in the domestic pharmaceutical market and it saw a growth of 10 per cent over the previous financial year. The pharmaceutical business is expected to touch $100 billion by 2025.

read this also- Get up to 50 lakh coverage from this post office scheme, these facilities will be available including taking a loan

- Advertisement -
Bhagyashree Soni
Bhagyashree Soni is a software engineer with soft writing skills. She is a degree holder from the International School of Entrepreneurial Leadership. She has been a state-level badminton champion and chess player. A woman with a forthright attitude enjoys her writing passion as her chosen career. Writing in the context of feminism, social-cause and entreprenurship is her forte.
Latest news
- Advertisement -spot_img
Related news
- Advertisement -spot_img

LEAVE A REPLY

Please enter your comment!
Please enter your name here